1. Home
  2. FCFS vs JAZZ Comparison

FCFS vs JAZZ Comparison

Compare FCFS & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

HOLD

Current Price

$232.77

Market Cap

8.9B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$221.59

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCFS
JAZZ
Founded
1988
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
10.4B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
FCFS
JAZZ
Price
$232.77
$221.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
$210.67
$217.57
AVG Volume (30 Days)
305.9K
890.7K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
0.78%
N/A
EPS Growth
29.49
N/A
EPS
2.43
4.43
Revenue
$3,661,043,000.00
$1,618,693,000.00
Revenue This Year
$16.20
$6.22
Revenue Next Year
$8.35
$7.68
P/E Ratio
$93.61
$50.94
Revenue Growth
8.04
N/A
52 Week Low
$119.21
$105.00
52 Week High
$230.72
$230.40

Technical Indicators

Market Signals
Indicator
FCFS
JAZZ
Relative Strength Index (RSI) 75.39 68.01
Support Level $178.72 $128.87
Resistance Level N/A N/A
Average True Range (ATR) 7.31 5.90
MACD 1.03 1.99
Stochastic Oscillator 97.99 77.29

Price Performance

Historical Comparison
FCFS
JAZZ

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: